We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Recalling OTC Domperidone After UK Concludes Drug Requires Prescription
J&J Recalling OTC Domperidone After UK Concludes Drug Requires Prescription
Johnson & Johnson is pulling its OTC nausea and vomiting drug domperidone from the UK market following a decision by regulators that the medicine must require a prescription to obtain due to risks of serious cardiac effects.